Ignite Creation Date:
2025-12-24 @ 6:33 PM
Ignite Modification Date:
2026-03-01 @ 1:27 PM
Study NCT ID:
NCT03268057
Status:
COMPLETED
Last Update Posted:
2022-05-02
First Post:
2017-08-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung Cancer
Sponsor:
Vaccinex Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
VX15/2503-04
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |